Blood cancer driver Musashi-2 as therapeutic target in chronic lymphocytic leukemia

Leukemia. 2021 Apr;35(4):982-983. doi: 10.1038/s41375-021-01144-1. Epub 2021 Mar 2.

Authors

Lukas Kazianka¹, Philipp B Staber²

Affiliations

¹ Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
² Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. philipp.staber@meduniwien.ac.at.

PMID: 33654207
DOI: 10.1038/s41375-021-01144-1

No abstract available

Publication types

Comment

MeSH terms

Apoptosis
Cell Survival
Hematologic Neoplasms*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy